Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Greensfelder Partners With Homethrive to Offer Family Elder Care Benefit to Employees


Today Greensfelder, Hemker & Gale, P.C. announced it is partnering with Homethrive, a family elder care coordinator, to offer all of its employees a fully covered family caregiver service benefit as part of the firm’s broader benefits package.

Available immediately, the firm is offering the benefit to all employees across its St. Louis, Chicago, and Southern Illinois offices. Through Homethrive, the firm’s employees will have individual access to Care Guides who provide bespoke coaching and concierge services for aging loved ones who live at home. Care Guides work with employees to learn about the loved one, identify opportunities and arrange third-party services, reducing employee stress and helping shoulder the burden of caregiving.

Offering a caregiver benefit builds upon the firm’s commitment to increased mental health offerings and overall support to employees through the Greensfelder Well-Being Program. In addition, it builds on parental and remote work policies that help create an equitable, inclusive, and supportive environment. The firm’s support programs for all stages of family life include a reintegration program for those on extended leave, parent mentoring services, counseling services, and other benefits. The Homethrive partnership adds an important new dimension to those offerings.

“We are excited to be partnering with Homethrive to offer a family caregiving benefit that helps us give employees the support they need,” said Kevin T. McLaughlin, Greensfelder’s President and CEO. “We hope that by offering this benefit, we are not only able to reduce stress and increase productivity but also improve our employees’ overall well-being in all aspects of their lives.”

The hidden caregiver crisis affects employees and companies, ultimately having the potential to affect worker productivity and cut short otherwise successful careers. According to a Harvard Business School survey, a third of employees who left a position due to caregiving reported taking care of an elder with daily living needs as a reason for leaving their job.

“We are thrilled to be partnering with Greensfelder to offer their employees, who are also caregivers, the support they need when caring for an aging loved one,” said David Greenberg, Co-founder & Co-CEO at Homethrive. “Greensfelder smartly recognizes that the pandemic is a particularly stressful and overwhelming time for those who are primary caregivers to parents who live nearby and far away. Offering a caregiving benefit will have a positive impact on their employees of all ages, many of whom are worried about an aging parent more than ever before.”

About Greensfelder:

Greensfelder, Hemker & Gale, P.C., founded in 1895, is a full-service law firm with offices in St. Louis, Chicago and Southern Illinois. Greensfelder offers comprehensive legal solutions for clients locally, nationally and internationally. Areas of practice include business services; communications and media; construction; educational, religious and tax-exempt organizations; employee benefits; employment and labor; energy; franchising and distribution; health care; intellectual property; litigation; real estate; securities and financial services; and trusts and estates. Find out more at http://www.greensfelder.com.

About Homethrive:

Homethrive is a family elder care coordination service that reduces the work, worry, and stress on a family caregiver. The company takes the uncertainty and stress out of caring for an aging loved one by offering expert coaching and concierge services by assigning an experienced Care Guide to each family. The company’s Care Guides also recommend and arrange any necessary third-party supportive services to provide meals, transportation, home care, medication delivery, or other services. To learn more, visit http://www.homethrive.com.

Share article on social media or email:

XPose Therapeutics embarks on the discovery and development of novel oncology medicines targeting DNA Damage Response with non-dilutive funding from NCI


We are bringing our extensive team training in some of the best research laboratories with pioneering experience in drug discovery; crystallography and structural biochemistry; and biology of DNA-binding and DNA repair proteins to a pipeline of DDR therapeutics

The modulation of DNA Damage Response (DDR) proteins is an emerging path to develop novel oncology therapeutics. XPose Therapeutics (XPose) is using a unique hit-to-lead approach to rapidly identify and build novel, target-specific DDR modulators. Our strategy starts with experimental poses of molecular fragments bound to DDR targets in 3D crystal structures, determined by high-throughput protein X-ray crystallography (hence XPose). Our lead target is a base excision repair DDR enzyme implicated in multiple cancers. Numerous inhibitors of this target have been identified previously by conventional methods like high-throughput screening, computational screening and pharmacophore modeling of commercially available molecules. However, no drugs are yet on the market. This limited progress reflects key drawbacks in the current inhibitors. The development of a successful selective inhibitor will find therapeutic use for several cancers, with the potential to be employed in synthetic lethality and combination therapy paradigms. XPose has identified a collection of novel fragment hits, distinct from other molecules for this target, and solely owns and controls all chemical matter IP. The XPose DDR target pipeline is being bolstered with additional targets, for which the same approach to generate hits and accelerate early discovery of novel chemical matter will be applied.

“XPose Therapeutics, Inc. is in a breakthrough position to pursue drug discovery and development on our lead target,” said Patricia Pellicena, PhD, VP of Biochemical and Cellular Pharmacology at XPose.

“This NCI-supported non-dilutive grant funding via an SBIR Phase I award will help us ramp up efforts on advancing the lead target program and provides a significant boost on top of the acceptance of XPose into the Berkeley SkyDeck HotDesk (Incubator) program in the Spring 2020 session. And to meet our growing needs, we are also excited about taking up residence in new laboratory space at MBC BioLabs in San Carlos, which excels in bringing state-of-the-art equipment, infrastructure and services to the local startup community,” said Debanu Das, PhD, Co-Founder and CEO of XPose.

About XPose

With help from QB3, San Francisco Bay Area-based XPose Therapeutics was founded in Fall 2019 by seasoned scientists, entrepreneurs and professionals in drug discovery, structural biology, chemistry and target biology to leverage a cutting-edge approach using experimental information on 3D protein-ligand interactions as a starting point to discover and develop target-specific small molecule cancer therapeutics for undruggable targets. The XPose focus is on DNA Damage Repair (DDR) proteins and their demonstrated roles in cancer. The compounds we discover and develop can be deployed in a multi-pronged approach across two modalities: monotherapy involving enzyme inhibition, synthetic lethality or targeted-protein degradation; and combination therapy with other genotoxins and cytostatics, thereby providing a significantly large therapeutic landscape to help a wide variety of patients.

Disclaimer

XPose Therapeutics is supported by the National Cancer Institute of the National Institutes of Health (NIH) under Award Number R43CA254552, The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Share article on social media or email:

Catalina Island Medical Center Welcomes Tammy Moore as Chief Operating Officer


Catalina Island Medical Center (CIMC) is proud to announce the appointment of Dr. Tammy Moore as Chief Operating Officer.

Dr. Moore comes to Catalina from a critical access hospital in Washington State where she served in numerous leadership roles, the most recent as Chief Clinical Officer. Throughout her fourteen years at Summit Pacific Medical Center in Elma, WA, Dr. Moore assisted in leading the organization through rapid growth and change as they built a new hospital and family practice clinic to replace aging structures and meet the needs of the community. In her roles as Medical Staff President and Vice President of Care Transformation, Dr. Moore successfully built relationships with nursing and medical staff and as CCO she oversaw innovation efforts that focused on payment reform and redesign of healthcare delivery in Western Washington State. Most recently, Dr. Moore led Summit through its pandemic response.

Dr. Moore holds a Bachelor’s of Science Degree in Nursing and a Master’s Degree of Nursing Science from Washington State University, as well as a Doctorate of Nursing Practice from Frontier Nursing University. Her doctoral work was dedicated to the implementation of accountable care organizations in rural areas.

Dr. Moore is excited to launch the next step in her career by serving as Chief Operating Officer (COO) of CIMC. The position comes at a pivotal time in the history of CIMC, which is immersed in a multi-faceted, time-sensitive fundraising drive aimed at constructing a new state-of-the-art healthcare facility to serve residents and visitors on Santa Catalina Island. The 2030 California earthquake safety requirements mandate that CIMC must build a new hospital to continue to ensure quality healthcare access on Catalina Island and meet the rapidly developing needs of its residents and patients.

Share article on social media or email:

Scientists Closing in on ‘Holy Grail’ for Neck, Back Pain


Dr. Kaliq Chang

Chronic pain, in general, affects some 40 percent of the U.S. population. Yet, experts decry the lack of new-drug development for pain management and the dearth of long-term studies to find proven non-pharmacologic therapies for treating neck and back pain.

Back and neck pain is reaching what some experts call epidemic proportions worldwide, but are scientists any closer to finding a “Holy Grail” of medicines for safe, long-term relief?

“Quite possibly,” says interventional pain management specialist Kaliq Chang MD of the New York- and New Jersey-based Atlantic Spine Center. He cites the latest study results, released in June 2020, indicating that a new, injectable drug, Tanezumab, a monoclonal antibody, may offer extended reduction of chronic lower back and neck pain and improve movement and function by blocking action of a specific protein – a nerve growth factor.

“If eventually approved by the FDA, this medication could prove a welcome alternative to opioids, such as morphine and oxycodone, which are addictive with potentially life-threatening side effects, and to non-steroidal anti-inflammatory drugs like ibuprofen, acetaminophen and aspirin whose effects are often limited and may be deemed inadequate by the patient,” says Dr. Chang.

He agrees with the Agency for Health Research and Quality, that, for too long, use of opioids has been an “easy remedy” for both acute and chronic pain and has “fueled the current opioid crisis” in the United States. In fact, abuse of prescription opioids is considered a major risk for heroin use.

Dr. Chang also notes a 2018 report in the Journal of the American Medical Association indicating that chronic-pain patients given opioid medications fared no better than those on non-opioid drugs. The study involved 240 randomized patients, many of whom suffered back pain.

Neck and back pain are considered leading causes globally for long-term disability, lost work days and the expenditure of literally billions of health care dollars and the third most common reason why patients in the United States visit the doctor’s office. Among causes of such pain are degeneration of vertebrae, primarily due to osteoarthritis, osteoporosis and other effects of aging; structural problems of the spine, including herniated discs that pinch nerves, and stenosis, a narrowing of the spinal column; continuous overuse or improper use of neck and back muscles; injury; and lifestyle issues, such as obesity and smoking.

Chronic pain, in general, affects some 40 percent of the U.S. population. Yet, experts decry the lack of new-drug development for pain management and the dearth of long-term studies to find proven non-pharmacologic therapies for treating neck and back pain. As one leading researcher at the University of Rochester School of Medicine put it: there has not been a drug “in maybe 100 years developed with a new way of affecting chronic pain.”

But the medication drought could be ending, Dr. Chang says. He points to a 2019 study in Science Advances, in which scientists from the University of Bonn (Germany) announce discovery of how opioids bind to three of the body’s pain receptors (special sensory neurons). They indicate that developing drugs targeting only one of these receptors – DOP – could prevent addiction and serious side effects, including respiratory paralysis.

Another scientific group – from Thomas Jefferson University in Philadelphia — has published findings identifying a physiologic process that changes the function of a pain receptor, thereby causing cellular dysfunction and a higher sensitivity to pain. The researchers suggest drugs might be developed to block this process.

Of course, until some new wonder medication appears on the horizon, pain management specialists must continue relying on the pharmacologic tools at hand, Dr. Chang states. For both neck and back pain, these tools include first-line over-the-counter agents such as analgesics for pain relief, non-steroidal anti-inflammatory medications, and topical applications in the form of creams, gels, and ointments. Among prescribed medications are muscle relaxants; drugs that address nerve-related pain; anti-depressants to enhance production of the body’s natural pain killers — endorphins; orally taken corticosteroids; and, when absolutely necessary, opioids.

If pharmacologic and physical therapy approaches fail to mitigate pain, spinal and cervical drug injections can be a non-surgical option, Dr. Chang explains. Injections may be used to target a specific spinal nerve or treat pain in the sacroiliac joint (where the spine connects to the pelvis). Injectables also may relieve pain in a facet joint (found between nearly every pair of vertebrae) or to deposit drugs such as corticosteroids in the epidural spaces around the spine. Also successful in many chronic cases is the application of radiofrequency to heat an affected nerve, creating a lesion that prevents the nerve from continuing to transmit pain.

The best medicine, of course, is prevention. That is why Dr. Chang offers these tips to avoid developing chronic neck or back pain:


  •     Give a painful neck time to heal. Do not make quick, sudden head movements. Wear a cervical collar if necessary.
  •     Use proper lifting techniques for heavy or cumbersome items. That means keep the object close to the body and lift with the knees.
  •     Remain active and warm up and stretch before engaging in any exercises.
  •     Take frequent breaks when work requires constant stress on back, shoulder and neck muscles
  •     Sleep with your head on one pillow – not elevated on two or three.
  •     Maintain proper body posture. Walk or sit erect, back and shoulders straight.
  •     Follow a healthy lifestyle. That means get down to a proper weight and stop smoking.


And, if back or neck pain does develop and fails to respond to home remedies, contact an orthopedic or interventional pain management specialist as soon as possible to avoid it becoming a greater problem in the future, Dr. Chang advises.

Atlantic Spine Center is a nationally recognized leader for endoscopic spine surgery with several locations in NJ and NYC. http://www.atlanticspinecenter.com, http://www.atlanticspinecenter.nyc

Kaliq Chang, MD, is an interventional pain management specialist, double board-certified in interventional pain management and anesthesiology, at Atlantic Spine Center.

Share article on social media or email:

Verge Health Launches “Insights,” the First Fully-Integrated BI and Analytics Healthcare Platform for a Full View of Risk


Insights provides a new approach to risk and quality management and bolsters our core mission to help clients protect patients and margins. We continue to break down organizational silos and provide crucial visibility for healthcare organizations to progress in their high reliability journey.

Verge Health, which offers the only governance, risk, and compliance (GRC) platform purpose-built for healthcare, announced today the launch of the first fully-embedded Business Intelligence (BI) and analytics platform giving healthcare providers groundbreaking access to tools and information for driving high reliability. Insights includes AI-based tools to analyze data and present actionable views of risk and quality across the enterprise, enabling users to quickly track safety initiatives, compliance, and provider performance. This is a significant step in achieving zero harm.

“The healthcare industry is tired of being ‘data rich and information poor.’ Quick access to insightful information is paramount, especially as the market shifts to evolving payment models, changing regulations, and managing patient and employee safety throughout the COVID-19 pandemic,” said Connie Moser, chief executive officer of Verge Health. “Insights provides a new approach to risk and quality management and bolsters our core mission to help clients protect patients and margins. We continue to break down organizational silos and provide crucial visibility for organizations to progress in their high reliability journey.”

Verge knows that compliance and provider performance have an implicit connection to safety. Insights leverages all Converge Platform® data impacting safety to drive a proactive approach. Verge will offer Insights to all clients starting August 4, 2020, which will create a paradigm shift in the way clients glean information and drive action from the Converge Platform®. Organizations can now access a system-level view of compliance, including the ability to view findings via The Joint Commission’s SAFER Matrix or a Daily Safety Huddle dashboard that elevates safety events for easy review by departments, organizations, or health systems.

“Insights generates quality, safety and overall risk management from the front-line to the leadership team,” said Sharon Schneller, chief nursing officer at Olmsted Medical Center in Minnesota. “From my years as a Chief Nursing Officer, I know access to real-time safety information is key for front-line nurses to quickly communicate and react to issues. At the executive level, Insights will guide leaders where to focus and provide understanding around audits, education needs, and quality issues. The information provided by Insights will truly drive high reliability within a health system and positively impact every patient.”

About Verge Health: Since 2001, Verge Health has united safety and compliance with provider management to empower healthcare organizations to proactively protect and defend patients, caregivers, and facilities against errors, adverse events, and policy violations. We believe patients should be able to trust the doctors and staff responsible for their care, and that every healthcare organization should have the ability to derive the insights from their data necessary to provide high-quality service. That’s why we developed the Converge Platform — the only Governance, Risk, and Compliance platform purpose-built for healthcare (GRCH) — giving administrators and executives enterprise-wide visibility to potential risks. Only Verge combines this integrated platform with 360-degree analytics and Strategic Advisory Services to help clients establish a culture that prioritizes “zero harm.” Headquartered in Charleston, SC, Verge works with half a million users in more than 900 healthcare organizations and payers across the country, helping them protect their patients and bottom line. For more information, visit us at http://www.vergehealth.com and follow us at @vergehealth.

Share article on social media or email:

TWG Benefits Enhances Advisor-Led Experiences with iJoin


iJoin Logo

iJoin is a real differentiator when it comes to partnering with advisors.

TWG Benefits, Inc. (TWG) and LDI-MAP LLC (d.b.a. iJoin) have announced an agreement to incorporate iJoin’s goal-based retirement plan experience into TWG’s 401(k) open architecture offering. Headquartered in Northbrook, Illinois, TWG partners with advisors to serve more than 600 retirement plans. The addition of iJoin enables TWG to differentiate its enrollment and engagement model with a highly personalized experience tightly integrated with its recordkeeping platform.

TWG’s collaborative model with financial advisors focuses on expert plan design to optimize implementation, plan utility, and user success. iJoin’s goal-based enrollment and engagement platform makes it easy for TWG and its advisor partners to present a superior initial participant experience that leads to personalized engagement campaigns. iJoin’s technology also gives advisors actionable and sharable insights across all plans as it compares plan performance against industry benchmarks and identifies plan and participant trends for follow-up action.

TWG Principal Haskel Weiss said, “iJoin is a real differentiator when it comes to partnering with advisors. It evolves conversations with plan sponsors from funds, fees and fiduciary issues to talking about how they are helping create better retirement outcomes.”

In its initial participant experience, iJoin answers the questions most people have about saving for retirement: How much will I need? Am I saving enough? How do I get on track? The application calculates each individual’s unique retirement funding goal based on their age, income, savings, location, gender and many other factors and then encourages them with specific and timely actions to help them reach their goal. TWG Principal Adam Weiss added, “It’s one thing to talk about goals. It’s another to deliver tangible results. We believe iJoin will help us do that.”

Steve McCoy, CEO of iJoin noted, “We’re excited to partner with TWG. They have long been an advocate for better technologies and best practices in elevating service delivery and supporting relationships. We’re looking forward to helping them introduce iJoin to their advisors and plans.”

About LDI-MAP, LLC (dba iJoin)

The iJoin team is committed to personalizing retirement success™ and making it easy for millions of savers to get on a path to better retirement outcomes. As a financial technology partner to the retirement plan industry, iJoin’s goal-based retirement plan enrollment experience helps people immediately understand their retirement funding need and encourages action to get on track. iJoin supports financial advisors and recordkeepers with actionable data and tools to more effectively engage both employers and their employees. LDI-MAP (d.b.a. iJoin) is a registered investment advisor with the State of Arizona – 14646 N. Kierland Boulevard, Suite 125 Scottsdale, AZ 85254. Learn more at ijoinsuccess.com.

About TWG Benefits

TWG Benefits provides daily valuation recordkeeping, actuarial, and third-party administrative (TPA) services to over 600 retirement plans with approximately 25,000 participants and plan assets in excess of $1 billion. TWG is headquartered in Northbrook, IL and maintains a physical presence in strategic regional markets to serve its nationwide client base. TWG is a second-generation family business that has helped people build wealth for a financially secure retirement across four decades. More at https://www.twgbenefits.com/.

Share article on social media or email:

Asthma and Allergy Foundation of America and PlatformQ Health Launch New Continuing Education Programs for Clinicians to Improve Patient Outcomes


“We are proud to partner with and support AAFA in their mission to improve the quality of lives for people with asthma, allergies and related conditions. We’ve seen the measurable impact online education has on these conditions, and look forward to continuously serving AAFA and their community.”

Building on the success of their partnership and the impact of the educational activities produced over the last few years, PlatformQ Health is excited to announce an expansion of its ongoing collaboration with the Asthma and Allergy Foundation of America (AAFA). Together over the next three years, they will produce a series of virtual continuing medical education (CME) and supplemental activities that will allow health care providers (HCPs), patients, and caregivers to connect online with leaders in the field, learn about disease management and treatment options, ask questions and hear personal testimonies from patients and caregivers about their experiences.

AAFA and PlatformQ Health have previously teamed up to address clinician and patient needs. Presentation of outcomes from an aligned educational initiative (patient and HCP programs ‘tethered’ around one topic) in atopic dermatitis was accepted at the American Academy of Allergy, Asthma and Immunology (AAAAI) and American Academy of Dermatology’s (AAD) Annual meetings, and shared online.

“We are excited to build on the work we started in 2018, to provide accessible, actionable education to health care providers and the families they serve,” shared Melanie Carver, Chief Mission Officer of AAFA. “PlatformQ Health’s interactive learning platform allows us to provide valuable and timely education to our community. Through this partnership, AAFA will further support people with asthma and allergies and their families, while elevating the voice of the patient. Clinician education cannot be overlooked – health professionals are a critical part of the patient journey and we’re excited to expand our CME offerings to help provide HCPs with more of the tools needed to diagnose, treat, and stay up to date with the latest medical research and information.”

Robert Rosenbloom, CEO of PlatformQ Health shared, “We are proud to partner with and support AAFA in their mission to improve the quality of lives for people with asthma, allergies and related conditions. We’ve seen the measurable impact online education has on these conditions and others, and look forward to continuously serving AAFA and their community as we can leverage our online learning platform to deliver education to the right person at the right time.”

Other leading foundations are using PlatformQ Health’s digital education platform to deliver outcomes-centric video-based medical education to HCPs and patients they serve, like the National Organization for Rare Disorders (NORD) and the Depression and Bipolar Support Alliance (DBSA). In addition to more than a dozen HCP and patient sessions, NORD utilized the platform to take their in-person conference online.

A History of Success in Allergy and Asthma Education

In May, PlatformQ Health published a virtual e-poster presentation featuring results from a recent aligned educational initiative in atopic dermatitis that was accepted at AAAAI and AAD’s Annual Meetings. The poster/video combination demonstrates learning design, delivery methods, and outcomes from the two sessions – one for clinicians and one for patients, with the two sharing similar learning objectives related to treatment and shared decision making. The unique educational design allowed PlatformQ Health and AAFA to identify critical areas of communication and missed opportunities for shared decision-making regarding atopic dermatitis management. Check out the full virtual presentation here.

A newly released aligned initiative in Chronic Spontaneous (Idiopathic) Urticaria (CSU or CIU), with dedicated activities for health care professionals and patients/caregivers. Further tethering the initiative, session insights and questions from the patient activity were discussed and addressed by the expert panel in the CME session. Both are available online for on demand viewing:

PQH and AAFA will be launching another tethered education program starting August 17th with a patient education program led by Dr. Peter Lio on MedLive. The expert faculty panel of this program, Taking Charge of my Eczema will also feature an advocacy specialist and a patient.

In September, the adjacent 2-part clinician-education program about atopic dermatitis will launch on ImmunologyLive: Part 1 – Aligning Treatment with Disease Burden and Severity to Optimize Success & Part 2 -Atopic Dermatitis: A Clear Roadmap to Treatment Success. Peter Lio MD, Clinical Assistant Professor of Dermatology & Pediatrics, Northwestern University Feinberg School of Medicine will lead a panel of other top experts as they discuss diagnosis, treatment options, improved symptom control and how to integrate components of shared decision-making that includes ongoing assessment of QoL.

About AAFA

Founded in 1953, AAFA is the oldest and largest non-profit patient organization dedicated to saving lives and reducing the burden of disease for people with asthma, allergies and related conditions through research, education, advocacy and support. AAFA offers extensive support for individuals and families affected by asthma and allergic diseases, such as food allergies and atopic dermatitis (eczema). Through its online patient support communities, network of local chapters and affiliated support groups, AAFA empowers patients and their families by providing practical, evidence-based information and community programs and services. AAFA is the only asthma and allergy patient advocacy group that is certified to meet the standards of excellence set by the National Health Council. For more information, visit http://www.aafa.org.

About PlatformQ Health

PlatformQ Health Education is the leading provider of interactive digital medical education for clinicians, patients, and caregivers. To improve patient care, PlatformQ Health Education creates video-first educational modules with premier partners, so learners can better understand conditions, available treatment options, and the latest research. The company’s proprietary platform allows participants to engage in real-time discussion with scientific, research and patient care experts – and the integrated learning solution enables advocates, administrators, health systems and plans, foundations, societies, member organizations and associations to measure the impact of their education. https://www.platformqhealth.com

Share article on social media or email:

Mount Sinai Medical Legal Partnership Names Executive Director


The Mount Sinai Medical Legal Partnership (MSMLP) has appointed Allison Charney as its Executive Director. Ms. Charney was a founding member of the MSMLP and has been Co-Chair of the Board of Directors since its inception in 2014.

Ms. Charney joins MSMLP in this role after working for 13 years as a partner in two top-tier law firms.

“Allison has stepped up right away working with MSMLP’s providers and pro bono attorneys to ensure that our patients in their greatest time of need still had access to legal services,” said Barbara Berger Opotowsky, MSMLP President.

Ms. Charney’s new role comes as the MSMLP has helped patients with COVID-19-related needs in obtaining unemployment benefits, visa extensions, public benefits, end-of-life planning, and custody of children. With the support of a centralized intake platform arranged for by MSMLP’s partner, LegalHealth, MSMLP has continued to provide free and confidential legal services for low-income Mount Sinai patients throughout the COVID-19 crisis.

“MSMLP has helped better serve our patients’ legal needs, which we know can lead to healthier outcomes,” said Beth Essig, Executive Vice President and General Counsel, Mount Sinai Health System, and MSMLP Founder and Advisory Board Member.

As patients return to Mount Sinai for routine care, MSMLP will continue its mission of providing free legal services ranging from special education advocacy for young patients to end-of-life planning at seven legal clinics throughout the Mount Sinai Health System.

MSMLP was founded to provide the most vulnerable of Mount Sinai’s patients with free legal services to prevent and remedy the social and environmental conditions that can negatively affect a patient’s overall well-being. MSMLP brings together lawyers and health care teams, implementing integrated approaches to holistically caring for Mount Sinai’s patients by giving patients legal help in areas including housing, education, benefits, family law issues, wills, and immigration.

“Allison brings to MSMLP extraordinary legal qualifications, and her commitment to access to legal services for all is evidenced by her many years of pro bono service. Allison first worked to create MSMLP; now as our new Executive Director, she will take MSMLP to the next level to improve the lives of Mount Sinai’s neediest patients,” said Bettina Plevan, partner at Proskauer Rose LLP, Chair of the MSMLP Board of Directors and a member of the Board of Trustees of the Mount Sinai Health System.

About the Mount Sinai Medical Legal Partnership

Mount Sinai Medical Legal Partnership, an independent, non-profit organization, provides Mount Sinai’s vulnerable patients with free legal service to prevent and remedy the social and environmental conditions that are rooted in legal issues, such as housing, education, personal safety, and access to health care. Bringing together lawyers and healthcare teams, the MSMLP implements an integrated approach to caring for Mount Sinai’s patients in its seven legal clinics and targeted programs throughout the Mount Sinai Health System. By addressing the legal issues and other non-medical determinants of illness, the MSMLP is improving the overall health of our patients and community. For more information, visit http://www.msmlp.org/.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

National Cannabis Courier Talaria Transportation Expands Fleet Network with New Headquarters in Ohio


Over the past year, we’ve experienced accelerated growth in the Midwest and it’s exciting to now have official headquarters in Ohio to meet the increasing needs of those accounts. This expansion is a testament to our dependability and future longevity in the industry.

Talaria Transportation, LLC (“Talaria”), a privately held company specializing in secure, compliant logistics for the legal cannabis industry, today announced the expansion of its fleet network with new headquarters in Columbus, Ohio. The company currently has facilities in Scranton, Pittsburgh, and corporate headquarters in Philadelphia.

Talaria has developed logistic partnerships with licensed cannabis cultivators, dispensaries, and brands across 14 state markets. The company offers safe and traceable cash management, product distribution, and fleet services for lab testing with its 130-person security team of former police officers and military veterans.

A transport provider for 223 dispensaries in total and more than a third of the operating medical cannabis dispensaries in Ohio, Talaria also acts as distributor for five of the 24 cultivation sites in the state. The Ohio medical marijuana market has showed steady growth in 2020, with over 100,000 registered patients and numbers increasing by an average of seven percent month-over-month, according to Marijuana Business Daily.

“Over the past year, we’ve experienced accelerated growth in the Midwest and it’s exciting to now have official headquarters in Ohio to meet the increasing needs of those accounts. This expansion is a testament to our dependability and future longevity in the industry,” stated CEO and Founder Ari Raptis who was named a Top 40 Under 40 Rising Star in Cannabis by Marijuana Venture magazine.

Since its establishment in 2017, Talaria has emerged as one of the premier transportation providers for the highly regulated cannabis industry due to its ability to ensure state-specific compliance measures, mitigate risk, and act as a single source solution for companies looking to expand their distribution.

For more information, visit Talaria.com.

About Talaria:

Established in 2017, Talaria Transportation, LLC is a privately held company specializing in secure logistics for the legal cannabis industry. Talaria is currently operating in 14 states and provides optimum systems for every facet of the market, including product, payment, cash processing, and lab testing transportation. With a professional team comprised of retired police officers and military veterans, the Company is dedicated to delivering health throughout the United States and North America. Talaria Transportation is headquartered at 3576 West Chester Pike, #373, Newtown Square, Pennsylvania, 19073. For information, visit Talaria.com.

Share article on social media or email:

Corstrata Wound & Ostomy Management is Powered by Citus Health


“We’ve been doing this for a long time,” says Katherine Piette, Co-Founder and CEO of Corstrata. “And, here is what we have learned…not all telehealth is the same.”

Corstrata, a leading, tech-enabled, virtual wound and ostomy management company, and Citus Health, a leading digital health solutions provider for the post-acute industry, announce a partnership today that will leverage the Citus Health platform as the core technology driving Corstrata Wound and Ostomy Management.

“We’ve been doing this for a long time,” says Katherine Piette, Co-Founder and CEO of Corstrata. “And, here is what we have learned…not all telehealth is the same.”

Katherine Piette, and her partner Joseph Ebberwein are veterans to the post-acute     environment. Terms such as Telehealth and Virtual Care are currently being used loosely, but the duo knows that depending on the site of care, there are actually a number of distinct and separate business models in Telehealth.

“Not everyone can do what we do!” says Ebberwein. Corstrata has been preparing for years for this moment. The intricately weaving of state compliance and licensure with the know-how of best practice clinical guidelines and driven within an agile, timely access to the right clinical resource supports the patient and provider to achieve optimal clinical and financial outcomes.

“We’ve learned that we had to respond to our customers’ workflows better than anyone else…which requires an incredibly agile, technology platform,” said Piette. “Although we have a number of technology partners in our total platform solution, Citus Health offers us the rich patient, care team and provider engagement options we need to deliver a powerful virtual solution.” After an extensive search and review, Corstrata recognized that there was no single technology company that could offer a full suite solution in Telehealth for Wound Care. “Wound and ostomy care simply require more features,” says Piette. “We are pleased that Citus Health has such a robust platform that will help us differentiate ourselves and better serve the marketplace.”

Melissa Kozak, RN, CRNI, and Chief Executive Officer of Citus Health, added, “Founders, Katherine Piette and Joseph Ebberwein, are two of the most committed individuals in this country working to address the challenges of access to wound care experts. And in today’s virtual environment, it’s more important than ever for post-acute providers and care teams to have access to proven remote care technology. The Corstrata team is dedicated to enabling providers and care teams with the leading-edge solutions that solve the tremendous challenges they face in delivering the critical access to wound and ostomy experts across the country.”

Corstrata powered by Citus Health will provide wound and ostomy patients, providers, care teams, and diabetic foot ulcer prevention members with secure, HIPAA-compliant telehealth solutions for enhanced care team collaboration and communication to improve outcomes for wound and ostomy patients. The Citus Health platform is built to connect multiple stakeholders, including patients, from any device, anywhere, removing barriers to engagement and delays in care that improve patient and financial outcomes. The combined Corstrata and Citus Health platforms integrate the key technologies, including real-time messaging and video sessions, wound image capture and more, needed to provide optimal wound care management in a remote care setting.

Two and a half years ago, when Piette and Ebberwein approached Kozak, it was such a novel idea to offer intensive Wound Care assessment and treatment planning outside of a physician’s office or wound clinic setting. But it would seem the hard work is now ready to pay off.

“COVID-19 will forever impact the way we deliver healthcare,” says Ebberwein. “The outbound calls used to require removing the ‘we can’t’ barriers, and now inbound phone calls at Corstrata reflect a ‘how quickly can you?’ dialog. We are leading the way during this new era of ‘Wound Centers Without Walls.’”

“When we were selected as a Corstrata’s partner a couple of years ago, both of our companies were in exploration mode finding our way through innovative service protocols,” says Kozak. “We are honored that Corstrata has chosen the Citus Health platform as their core technology to help them fulfill their promise of delivering world-class wound and ostomy care through tech-empowered access to tech-empowered board certified wound care clinicians.”

About Citus Health

Citus Health is a digital health transformation leader that enables real-time, secure collaboration between patients, care teams, care partners, and family members to optimize the patient experience and positively impact the financial outcome of the care provider. Founded by a post-acute care nurse with domain expertise, and an internationally recognized digital health expert, Citus Health delivers the only comprehensive on-demand digital and mobile platform that sets a new standard of patient, caregiver, family, and partner engagement. For more information, visit citushealth.com.

About Corstrata

Corstrata enables Post-Acute Providers – home health agencies, hospices, rehab hospitals, and nursing homes – to easily manage complex & chronic wounds more profitably with its turn-key Nurse2Nurse consults and wound care management services. Corstrata’s senior-level, wound-certified nursing team is comprised of some of the best and most experienced in the industry. Corstrata couples wound expertise with the most advanced, cost-effective wound dressings, latest evidence-based treatments, and a telehealth infrastructure to ensure delivery of the right patient support at the greatest point of need – the bedside.

Share article on social media or email: